633 related articles for article (PubMed ID: 31446140)
1. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma.
Zhang C; Zhang J; Xu FP; Wang YG; Xie Z; Su J; Dong S; Nie Q; Shao Y; Zhou Q; Yang JJ; Yang XN; Zhang XC; Li Z; Wu YL; Zhong WZ
J Thorac Oncol; 2019 Nov; 14(11):1912-1923. PubMed ID: 31446140
[TBL] [Abstract][Full Text] [Related]
2. Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers.
Hu C; Zhao L; Liu W; Fan S; Liu J; Liu Y; Liu X; Shu L; Liu X; Liu P; Deng C; Qiu Z; Chen C; Jiang Y; Liang Q; Yang L; Shao Y; He Q; Yu D; Zeng Y; Li Y; Pan Y; Zhang S; Shi S; Peng Y; Wu F
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34887263
[TBL] [Abstract][Full Text] [Related]
3. Evolution of lung adenocarcinoma from preneoplasia to invasive adenocarcinoma.
Zhu J; Wang W; Xiong Y; Xu S; Chen J; Wen M; Zhao Y; Lei J; Jiang T
Cancer Med; 2023 Mar; 12(5):5545-5557. PubMed ID: 36325966
[TBL] [Abstract][Full Text] [Related]
4. Distinct mutational features across preinvasive and invasive subtypes identified through comprehensive profiling of surgically resected lung adenocarcinoma.
Xiang C; Ji C; Cai Y; Teng H; Wang Y; Zhao R; Shang Z; Guo L; Chen S; Lizaso A; Lin J; Wang H; Li B; Zhang Z; Zhao J; Wei J; Liu J; Zhu L; Fang W; Han Y
Mod Pathol; 2022 Sep; 35(9):1181-1192. PubMed ID: 35641658
[TBL] [Abstract][Full Text] [Related]
5. Genomic and immune profiling of pre-invasive lung adenocarcinoma.
Chen H; Carrot-Zhang J; Zhao Y; Hu H; Freeman SS; Yu S; Ha G; Taylor AM; Berger AC; Westlake L; Zheng Y; Zhang J; Ramachandran A; Zheng Q; Pan Y; Zheng D; Zheng S; Cheng C; Kuang M; Zhou X; Zhang Y; Li H; Ye T; Ma Y; Gao Z; Tao X; Han H; Shang J; Yu Y; Bao D; Huang Y; Li X; Zhang Y; Xiang J; Sun Y; Li Y; Cherniack AD; Campbell JD; Shi L; Meyerson M
Nat Commun; 2019 Nov; 10(1):5472. PubMed ID: 31784532
[TBL] [Abstract][Full Text] [Related]
6. [Immune Microenvironment Comparation Study between EGFR Mutant and EGFR Wild Type Lung Adenocarcinoma Patients Based on TCGA Database].
Zhu G; Li Y; Shi R; Xu S; Zhang Z; Cao P; Chen C; Liu H; Chen J
Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):236-244. PubMed ID: 33910272
[TBL] [Abstract][Full Text] [Related]
7. Differences in Immunological Landscape between
Luo JW; Guo YH; Wu FY; Li XF; Sun XC; Wang JL; Zhou CC
Dis Markers; 2021; 2021():3776854. PubMed ID: 34484468
[TBL] [Abstract][Full Text] [Related]
8. Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features.
Dejima H; Hu X; Chen R; Zhang J; Fujimoto J; Parra ER; Haymaker C; Hubert SM; Duose D; Solis LM; Su D; Fukuoka J; Tabata K; Pham HHN; Mcgranahan N; Zhang B; Ye J; Ying L; Little L; Gumbs C; Chow CW; Estecio MR; Godoy MCB; Antonoff MB; Sepesi B; Pass HI; Behrens C; Zhang J; Vaporciyan AA; Heymach JV; Scheet P; Lee JJ; Wu J; Futreal PA; Reuben A; Kadara H; Wistuba II; Zhang J
Nat Commun; 2021 May; 12(1):2722. PubMed ID: 33976164
[TBL] [Abstract][Full Text] [Related]
9. Genomic landscape and tumor mutational features of resected preinvasive to invasive lung adenocarcinoma.
Lin Y; Li D; Hui H; Miao H; Luo M; Roy B; Chen B; Zhang W; Shao D; Ma D; Jie Y; Qiu F; Li H; Jiang B
Front Oncol; 2024; 14():1389618. PubMed ID: 38803537
[TBL] [Abstract][Full Text] [Related]
10. Genomic Underpinnings of Tumor Behavior in
Qian J; Zhao S; Zou Y; Rahman SMJ; Senosain MF; Stricker T; Chen H; Powell CA; Borczuk AC; Massion PP
Am J Respir Crit Care Med; 2020 Mar; 201(6):697-706. PubMed ID: 31747302
[No Abstract] [Full Text] [Related]
11. Genetic Alterations in Preinvasive Lung Synchronous Lesions.
Ahn S; Lim J; Park SY; Kim H; Kwon HJ; Han YB; Lee CT; Cho S; Chung JH
Cancer Res Treat; 2020 Oct; 52(4):1120-1134. PubMed ID: 32599981
[TBL] [Abstract][Full Text] [Related]
12. Expression of PD-L1 through evolution phase from pre-invasive to invasive lung adenocarcinoma.
Zhou J; Lin H; Ni Z; Luo R; Yang D; Feng M; Zhang Y
BMC Pulm Med; 2023 Jan; 23(1):18. PubMed ID: 36647116
[TBL] [Abstract][Full Text] [Related]
13. Distinctive clinicopathological features of adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung: A retrospective study.
Ishida H; Shimizu Y; Sakaguchi H; Nitanda H; Kaneko K; Yamazaki N; Yanagihara A; Taguchi R; Sakai F; Yasuda M; Kobayashi K
Lung Cancer; 2019 Mar; 129():16-21. PubMed ID: 30797486
[TBL] [Abstract][Full Text] [Related]
14. Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study.
Shi J; Hua X; Zhu B; Ravichandran S; Wang M; Nguyen C; Brodie SA; Palleschi A; Alloisio M; Pariscenti G; Jones K; Zhou W; Bouk AJ; Boland J; Hicks B; Risch A; Bennett H; Luke BT; Song L; Duan J; Liu P; Kohno T; Chen Q; Meerzaman D; Marconett C; Laird-Offringa I; Mills I; Caporaso NE; Gail MH; Pesatori AC; Consonni D; Bertazzi PA; Chanock SJ; Landi MT
PLoS Med; 2016 Dec; 13(12):e1002162. PubMed ID: 27923066
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary Adenocarcinoma In Situ and Minimally Invasive Adenocarcinomas in European Patients Have Less
Petterson J; Mustafa D; Bandaru S; Eklund EÄ; Hallqvist A; Sayin VI; Gagné A; Fagman H; Akyürek LM
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474205
[TBL] [Abstract][Full Text] [Related]
16. Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors.
Yang CY; Liao WY; Ho CC; Chen KY; Tsai TH; Hsu CL; Su KY; Chang YL; Wu CT; Hsu CC; Liao BC; Hsu WH; Lee JH; Lin CC; Shih JY; Yang JC; Yu CJ
Eur J Cancer; 2020 Jan; 124():110-122. PubMed ID: 31760310
[TBL] [Abstract][Full Text] [Related]
17. Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma.
Hu X; Fujimoto J; Ying L; Fukuoka J; Ashizawa K; Sun W; Reuben A; Chow CW; McGranahan N; Chen R; Hu J; Godoy MC; Tabata K; Kuroda K; Shi L; Li J; Behrens C; Parra ER; Little LD; Gumbs C; Mao X; Song X; Tippen S; Thornton RL; Kadara H; Scheet P; Roarty E; Ostrin EJ; Wang X; Carter BW; Antonoff MB; Zhang J; Vaporciyan AA; Pass H; Swisher SG; Heymach JV; Lee JJ; Wistuba II; Hong WK; Futreal PA; Su D; Zhang J
Nat Commun; 2019 Jul; 10(1):2978. PubMed ID: 31278276
[TBL] [Abstract][Full Text] [Related]
18. Targeted next-generation sequencing for analyzing the genetic alterations in atypical adenomatous hyperplasia and adenocarcinoma in situ.
Xu X; Li N; Zhao R; Zhu L; Shao J; Zhang J
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2447-2453. PubMed ID: 28821955
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor mutations in adenocarcinoma in situ and minimally invasive adenocarcinoma detected using mutation-specific monoclonal antibodies.
Nakamura H; Koizumi H; Kimura H; Marushima H; Saji H; Takagi M
Lung Cancer; 2016 Sep; 99():143-7. PubMed ID: 27565930
[TBL] [Abstract][Full Text] [Related]
20. Detection and treatment of lung adenocarcinoma at pre-/minimally invasive stage: is it lead-time bias?
Ma Z; Wang Z; Li Y; Zhang Y; Chen H
J Cancer Res Clin Oncol; 2022 Oct; 148(10):2717-2722. PubMed ID: 35524781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
